On July 20, Qingsong Health fell 8.56% in regular trading, trading at 6.05 HKD/share, with turnover of approximately 55.02 million HKD. The decline reflects continued selling pressure following the company's profit warning issued on July 17.
According to the filing, Qingsong Health expects to record a net loss attributable to shareholders of approximately 40 million to 70 million RMB for the first half of the year, compared with a profit of approximately 86 million RMB in the same period last year — a sharp swing from profit to loss. The company attributed the deterioration primarily to significantly increased R&D expenditure on artificial intelligence model training and related areas.
Since the profit warning was released, the stock has been under sustained pressure, with market capitalization declining to approximately 1.3 billion HKD. Market concerns over the company's near-term profitability persist as investors weigh the heavy AI-related spending against uncertain returns. The interim results remain under preparation and are based on unaudited management accounts.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments